BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14678276)

  • 21. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.
    Itai T; Tanaka M; Nagata S
    Eur J Biochem; 2001 Apr; 268(7):2074-82. PubMed ID: 11277930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
    Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
    Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction.
    Shimoda Y; Satoh M; Nakamura M; Akatsu T; Hiramori K
    Clin Sci (Lond); 2005 Apr; 108(4):339-47. PubMed ID: 15603556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate.
    Hurtado O; Lizasoain I; Fernández-Tomé P; Alvarez-Barrientos A; Leza JC; Lorenzo P; Moro MA
    J Cereb Blood Flow Metab; 2002 May; 22(5):576-85. PubMed ID: 11973430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
    FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
    Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
    PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture.
    Zhao J; Chen H; Wang YL; Warburton D
    Int J Dev Biol; 2001 Jun; 45(4):623-31. PubMed ID: 11460998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertonicity-enhanced TNF-α release from activated human monocytic THP-1 cells requires ERK activation.
    Chou YC; Sheu JR; Chung CL; Hsiao CJ; Hsueh PJ; Hsiao G
    Biochim Biophys Acta; 2011 Apr; 1810(4):475-84. PubMed ID: 21256190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.
    Hilliard VC; Frey MR; Dempsey PJ; Peek RM; Polk DB
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G338-46. PubMed ID: 21617117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells.
    Bzowska M; Jura N; Lassak A; Black RA; Bereta J
    Eur J Biochem; 2004 Jul; 271(13):2808-20. PubMed ID: 15206946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing.
    Merlos-Suárez A; Fernández-Larrea J; Reddy P; Baselga J; Arribas J
    J Biol Chem; 1998 Sep; 273(38):24955-62. PubMed ID: 9733803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
    Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol.
    Zhang Z; Cork J; Ye P; Lei D; Schwarzenberger PO; Summer WR; Shellito JE; Nelson S; Kolls JK
    J Leukoc Biol; 2000 Jun; 67(6):856-62. PubMed ID: 10857859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNF alpha into sTNF alpha.
    Wang Z; Wang Y; Zhu K; Guo L; Yang Y
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):116-20. PubMed ID: 12973924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme.
    Slack BE; Ma LK; Seah CC
    Biochem J; 2001 Aug; 357(Pt 3):787-94. PubMed ID: 11463349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers.
    Gilles S; Zahler S; Welsch U; Sommerhoff CP; Becker BF
    Cardiovasc Res; 2003 Dec; 60(3):608-16. PubMed ID: 14659806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation.
    Sharma M; Mohapatra J; Wagh A; Patel HM; Pandey D; Kadam S; Argade A; Deshpande SS; Shah GB; Chatterjee A; Jain MR
    Cytokine; 2014 Mar; 66(1):30-9. PubMed ID: 24548422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme.
    Zhang Y; Hegen M; Xu J; Keith JC; Jin G; Du X; Cummons T; Sheppard BJ; Sun L; Zhu Y; Rao VR; Wang Q; Xu W; Cowling R; Nickerson-Nutter CL; Gibbons J; Skotnicki J; Lin LL; Levin J
    Int Immunopharmacol; 2004 Dec; 4(14):1845-57. PubMed ID: 15531300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.